Lineage Cell Therapeutics (United States)
Lineage Cell Therapeutics, Inc. is a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs. Lineage’s programs are based on its robust proprietary cell-based therapy platform and associated in-house development and manufacturing capabilities. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Lineage Cell Therapeutics (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
55%
Total
Publications
153
Total Open
Publications
84
Total
Citations
7K
Open Access
Percentage
55%
Total
Publications
153
Total Open
Publications
84
Total
Citations
7K
Breakdown
Publisher Open
15%
Both
27%
Other Platform Open
12%
Closed
46%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 37%
23
Hybrid 33%
21
No Guarantees 30%
19
Other Platform Open
Domain 84%
51
Other Internet 26%
16
Institution 11%
7
Public 5%
3
Preprint 2%
1
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 50 |
DOI | Other Internet | 16 |
Europe PMC | Domain | 8 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 4 |
Figshare | Public | 3 |
University of Oslo - Duo Research Archive | Institution | 2 |
UNSW Sydney - UNSWorks | Institution | 1 |
Unknown Repository | Other Internet | 1 |
University of Southern Denmark - University of Southern Denmark Research Portal | Institution | 1 |
University of Melbourne - Minerva Access | Institution | 1 |